Xvivo Perfusion AB Statistics
Total Valuation
STO:XVIVO has a market cap or net worth of SEK 14.44 billion. The enterprise value is 14.06 billion.
Market Cap | 14.44B |
Enterprise Value | 14.06B |
Important Dates
The last earnings date was Tuesday, January 28, 2025.
Earnings Date | Jan 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
STO:XVIVO has 31.50 million shares outstanding. The number of shares has increased by 5.73% in one year.
Current Share Class | n/a |
Shares Outstanding | 31.50M |
Shares Change (YoY) | +5.73% |
Shares Change (QoQ) | -0.11% |
Owned by Insiders (%) | 0.42% |
Owned by Institutions (%) | 44.89% |
Float | 25.00M |
Valuation Ratios
The trailing PE ratio is 84.28 and the forward PE ratio is 86.92.
PE Ratio | 84.28 |
Forward PE | 86.92 |
PS Ratio | 17.56 |
PB Ratio | 6.70 |
P/TBV Ratio | 10.13 |
P/FCF Ratio | 355.81 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 94.01, with an EV/FCF ratio of 346.42.
EV / Earnings | 81.66 |
EV / Sales | 17.10 |
EV / EBITDA | 94.01 |
EV / EBIT | 159.15 |
EV / FCF | 346.42 |
Financial Position
The company has a current ratio of 4.58, with a Debt / Equity ratio of 0.02.
Current Ratio | 4.58 |
Quick Ratio | 3.30 |
Debt / Equity | 0.02 |
Debt / EBITDA | 0.23 |
Debt / FCF | 0.84 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.40% and return on invested capital (ROIC) is 2.65%.
Return on Equity (ROE) | 8.40% |
Return on Assets (ROA) | 2.40% |
Return on Invested Capital (ROIC) | 2.65% |
Return on Capital Employed (ROCE) | 3.97% |
Revenue Per Employee | 4.84M |
Profits Per Employee | 1.01M |
Employee Count | 170 |
Asset Turnover | 0.36 |
Inventory Turnover | 1.12 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.03% in the last 52 weeks. The beta is 2.09, so STO:XVIVO's price volatility has been higher than the market average.
Beta (5Y) | 2.09 |
52-Week Price Change | +67.03% |
50-Day Moving Average | 465.46 |
200-Day Moving Average | 469.33 |
Relative Strength Index (RSI) | 46.84 |
Average Volume (20 Days) | 60,740 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:XVIVO had revenue of SEK 822.42 million and earned 172.18 million in profits. Earnings per share was 5.44.
Revenue | 822.42M |
Gross Profit | 616.42M |
Operating Income | 88.35M |
Pretax Income | 199.95M |
Net Income | 172.18M |
EBITDA | 149.57M |
EBIT | 88.35M |
Earnings Per Share (EPS) | 5.44 |
Balance Sheet
The company has 415.52 million in cash and 34.04 million in debt, giving a net cash position of 381.48 million or 12.11 per share.
Cash & Cash Equivalents | 415.52M |
Total Debt | 34.04M |
Net Cash | 381.48M |
Net Cash Per Share | 12.11 |
Equity (Book Value) | 2.16B |
Book Value Per Share | 68.47 |
Working Capital | 635.57M |
Cash Flow
In the last 12 months, operating cash flow was 111.29 million and capital expenditures -70.70 million, giving a free cash flow of 40.59 million.
Operating Cash Flow | 111.29M |
Capital Expenditures | -70.70M |
Free Cash Flow | 40.59M |
FCF Per Share | 1.29 |
Margins
Gross margin is 74.95%, with operating and profit margins of 10.74% and 20.94%.
Gross Margin | 74.95% |
Operating Margin | 10.74% |
Pretax Margin | 24.31% |
Profit Margin | 20.94% |
EBITDA Margin | 18.19% |
EBIT Margin | 10.74% |
FCF Margin | 4.94% |
Dividends & Yields
STO:XVIVO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.73% |
Shareholder Yield | -5.73% |
Earnings Yield | 1.19% |
FCF Yield | 0.28% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
STO:XVIVO has an Altman Z-Score of 32.55.
Altman Z-Score | 32.55 |
Piotroski F-Score | n/a |